DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Ishihara H, Yamaguchi S, Nakao I. et al.
Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): A multi-centre, randomized, placebocontrolled, double-blind study.
Diabetes Obes Metab 2016;
18: 1207-1216
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.